Business planning to research and source the best contract research organisations (CROs).
A biotechnology company with expertise in cellular screening techniques for antimicrobial applications needed to plan all the preclinical value-chain activities to develop a new drug. It wished to subcontract the work that was beyond its expertise: molecular modelling, medicinal chemistry, ADME and laboratory animals.
It needed to have options that were financially acceptable and scientifically robust.
We studied how the company had developed the technology in order to define all the activities that should be subcontracted and executed to develop a new antimicrobial candidate drug.
We worked within the available budget based on the funding rounds that the company had achieved and on the commitments investors had given.
We proposed different international CROs which were specialists in their own field including companies based in the UK, Germany, Ukraine and China, seeking the best compromise between budget and reliability.
We defined the R&D plan. We achieved agreements with different CROs in various parts of the world by adjusting budgets and benefits.
We monitored the work ensuring correct process development and good coordination between the different teams involved in it.